Stay updated on Venetoclax and Novel Agents in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.

Latest updates to the Venetoclax and Novel Agents in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe history now shows Revision: v3.4.2 and removes Revision: v3.4.1 from the current view.SummaryDifference0.1%

- Check20 days agoChange DetectedThe history record now shows a new revision entry v3.4.1, replacing the previous revision v3.4.0.SummaryDifference0.1%

- Check27 days agoChange DetectedUI updates in the history view include a glossary toggle, color-coded additions (green) and deletions (red), and the revision label v3.4.0 replacing v3.3.4. These changes are cosmetic and pertain only to display of change history rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedThe history now includes Revision: v3.3.3. The entries for HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check91 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Novel Agents in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.